Clinical Trial Update: CAR-T Cell Therapy for Desensitization in Kidney Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating CAR-T cell therapy for desensitization in kidney transplantation is currently recruiting, sponsored by NIAID. The study targ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• CAR-T Cell Therapy for Desensitization (Chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplant, Kidney Failure | Phase 1 | Status: RECRUITING